|Bid||0.0000 x 1200|
|Ask||0.0000 x 1300|
|Day's Range||0.5510 - 0.7200|
|52 Week Range||0.3701 - 1.3700|
|Beta (5Y Monthly)||-0.54|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Global concerns over the spread of the novel coronavirus rocked stock markets on Monday. The spread of COVID-19 has been a major economic punch felt around the globe, and it's impacting production at Triangle firms – from Lenovo to Cree.
The planned merger of a Triangle company and an Israeli outfit has brought in a third company -- and leadership says it could be the makings of a "new Salix" for Raleigh.
The merger of a Triangle public drugmaker and an Israeli outfit led by former-Salix executives could have huge potential for Raleigh and its gastrointestinal candidates.
Even the best investor on earth makes unsuccessful investments. But serious investors should think long and hard about...